DR. VIOLETA CATALÁ
Specialist in Uroradiology
General Management
Head of the Prostate Imaging Area
Radiologist specialised in Uroradiology, head of the Uroradiology Area at Creu Blanca in Barcelona, and founder and director of Uroima and Quodemy. Her career combines clinical practice, research and medical education, with a particular focus on diagnostic imaging of prostate cancer.
For more than a decade she worked at Fundació Puigvert, a monographic centre of reference in Barcelona, where she consolidated her experience in close collaboration with urologists, nephrologists and uropathologists. This interdisciplinary approach still guides her practice: interpreting images in the context of each patient and providing information relevant to clinical decisions.
She is co-editor and author of the Atlas of Multiparametric Prostate MRI (Springer) and has published articles in international scientific journals. Her work has received awards and distinctions at national and international congresses, including recognition at the RSNA.
She currently collaborates as an advisor to Siemens Healthineers and Quibim on the development of artificial intelligence applications for prostate magnetic resonance imaging. Her interest lies in bringing innovation into clinical practice, from evaluating these tools to integrating them into the radiologist's work.
Her commitment to medical education led her to found Quodemy, a diagnostic imaging training platform based on real clinical cases. She has organised, directed and taught numerous courses endorsed by radiology and urology scientific societies, using a practical and interdisciplinary methodology.
Springer reference atlas
Vilanova JC, Catalá V, Algaba F, Laucirica O, editors. Atlas of Multiparametric Prostate MRI: With PI-RADS Approach and Anatomic-MRI-Pathological Correlation. Cham: Springer; 2018.
Recent prostate publications · 2026
Paesano N, Catalá V, Camean J, Olmedo TE, Gurovich JI, Ringa M, et al. Comparative Validation and Performance of the Barcelona- and ERSPC-MRI Predictive Model in an Ibero-American Population of Men Suspected of Having Prostate Cancer. Cancers (Basel). 2026;18(16):2541.
Paesano N, Camean J, Ringa M, López-Silva M, Koren G, Olmedo TE, et al. External Validation and Clinical Impact of the Barcelona Predictive Models for Detecting Significant Prostate Cancer in Prostate Biopsies in an Ibero-American Population. Cancers (Basel). 2026;18(11):1810.
Recent prostate publications · 2025 - 2023
Paesano N, Catalá V, Tcholakian L, Alomar X, Barranco MÁ, Hernández-Mancera J, et al. Validation of the Barcelona Magnetic Resonance Imaging Predictive Model for Significant Prostate Cancer Detection in Men Undergoing Mapping per 0.5 Mm-Core Targeted Biopsies of Suspicious Lesions and Perilesional Areas. Cancers (Basel). 2025;17(3):473.
Paesano N, Gutiérrez Vallecillo MJ, Catalá V, Tcholakian L, Alomar X, Barranco M, et al. Concordance Between the Expert Reading of Biparametric-MRI and the Nonexpert Multiparametric-MRI for the Detection of Clinically Significant Prostate Cancer: Clinical Implications. Clin Genitourin Cancer. 2024;22(6):102233.
Paesano N, Catalá V, Tcholakian L, Alomar X, Barranco M, Trilla E, et al. The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies. Int Braz J Urol. 2024;50(3):296–308.
Paesano N, Catala V, Tcholakian L, Trilla E, Morote J. A Systematic Review of the Current Status of Magnetic Resonance-Ultrasound Images Fusion Software Platforms for Transperineal Prostate Biopsies. Cancers (Basel). 2023;15(13):3329.
